Meta-analysis of Associations between ATM Asp1853Asn and TP53 Arg72Pro Polymorphisms and Adverse Effects of Cancer Radiotherapy

  • Su, Meng ;
  • Yin, Zhi-Hua ;
  • Wu, Wei ;
  • Li, Xue-Lian ;
  • Zhou, Bao-Sen
  • Published : 2015.01.22


Background: The ataxia telangiectasia mutated (ATM) protein and p53 play key roles in sensing and repairing radiation-induced DNA double strand breaks (DSBs). Accumulating epidemiological evidence indicates that functional genetic variants in ATM and TP53 genes may have an impact on the risk of radiotherapy-induced side effects. Here we performed a meta-analysis to investigate the potential interaction between ATM Asp1853Asn and TP53 polymorphisms and risk of radiotherapy-induced adverse effects quantitatively. Materials and Methods: Relevant articles were retrieved from PubMed, ISI Web of Science and the China National Knowledge Infrastructure (CNKI) databases. Eligible studies were selected according to specific inclusion and exclusion criteria. Odds ratios (ORs) and 95% confidence intervals (CIs) were pooled to estimate the association between ATM Asp1853Asn and TP53 Arg72Pro polymorphisms and risk of radiotherapy adverse effects. All analyses were performed using the Stata software. Results: A total of twenty articles were included in the present analysis. In the overall analysis, no significant associations between ATM Asp1853Asn and TP53 Arg72Pro polymorphisms and the risk of radiotherapy adverse effects were found. We conducted subgroup analysis stratified by type of cancer, region and time of appearance of side effects subsequently. No significant association between ATM Asp1853Asn and risk of radiotherapy adverse effects was found in any subgroup analysis. For TP53 Arg72Pro, variant C allele was associated with decreased radiotherapy adverse effects risk among Asian cancer patients in the stratified analysis by region (OR=0.71, 95%CI: 0.54-0.93, p=0.012). No significant results were found in the subgroup analysis of tumor type and time of appearance of side effects. Conclusions: The TP53 Arg72Pro C allele might be a protective factor of radiotherapy-induced adverse effects among cancer patients from Asia. Further studies that take into consideration treatment-related factors and patient lifestyle including environmental exposures are warranted.


ATM;TP53;polymorphisms;meta-analysis;radiotherapy;adverse effects;toxicity


  1. Alsbeih G, El-Sebaie M, Al-Harbi N, et al (2013). SNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkers. Radiat Oncol, 8, 125.
  2. Andreassen CN, Overgaard J, Alsner J, et al (2006). ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys, 64, 776-83.
  3. Angele S, Romestaing P, Moullan N, et al (2003). ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res, 63, 8717-25.
  4. Azria D, Ozsahin M, Kramar A, et al (2008). Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res, 14, 6284-8.
  5. Badie C, Dziwura S, Raffy C, et al (2008). Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br J Cancer, 98, 1845-51.
  6. Cesaretti JA, Stock RG, Lehrer S, et al (2005). ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Intern J Radiat Oncol Biol Phys, 61, 196-202.
  7. Chang-Claude J, Ambrosone CB, Lilla C, et al (2009). Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer, 100, 1680-6.
  8. Edvardsen H, Tefre T, Jansen L, et al (2007). Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. Radiat Oncol, 2, 25.
  9. Fachal L, Gomez-Caamano A, Peleteiro P, et al (2012). Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients. Radiother Oncol, 105, 321-8.
  10. Gotoff SP, Amirmokri E, Liebner EJ (1967). Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis. Am J Dis Child, 114, 617-25.
  11. Ho AY, Fan G, Atencio DP, et al (2007). Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. Intern J Radiat Oncol Biol Phys, 69, 677-84.
  12. Ishikawa A, Suga T, Shoji Y, et al (2011). Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy. Intern J Radiat Oncol Biol Phys, 81, 1144-52.
  13. Kastan MB, Bartek J (2004). Cell-cycle checkpoints and cancer. Nature, 432, 316-23.
  14. Kastan MB, Derheimer FA (2010). Multiple roles of ATM in monitoring and maintaining DNA integrity. Febs Letters, 584, 3675-81.
  15. Kastan MB, Lim DS (2000). The many substrates and functions of ATM. Nat Rev Mol Cell Biol, 1, 179-86.
  16. Kurz EU, Lees-Miller SP (2004). DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair, 3, 889-900.
  17. Lavin MF, Kozlov S (2007). ATM activation and DNA damage response. Cell Cycle, 6, 931-42.
  18. Morgan JL, Holcomb TM, Morrissey RW (1968). Radiation reaction in ataxia telangiectasia. Am J Dis Child, 116, 557-8.
  19. Pugh TJ, Keyes M, Barclay L, et al (2009). Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients. Clin Cancer Res, 15, 5008-16.
  20. Raabe A, Derda K, Reuther S, et al (2012). Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy. Radiat Oncol, 7, 65.
  21. Savitsky K, Platzer M, Uziel T, et al (1997). Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression. Nucleic Acids Res, 25, 1678-84.
  22. Stone HB, Coleman CN, Anscher MS, et al (2003). Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol, 4, 529-36.
  23. Tan XL, Popanda O, Ambrosone CB, et al (2006). Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treatment, 97, 255-62.
  24. Taylor AM, Harnden DG, Arlett CF, et al (1975). Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature, 258, 427-9.
  25. Terrazzino S, La Mattina P, Gambaro G, et al (2012a). Common variants of GSTP1, GSTA1, and TGF beta 1 are associated with the risk of radiation-induced fibrosis in breast cancer patients. Intern J Radiation Oncol Biol Phys, 83, 504-11.
  26. Terrazzino S, La Mattina P, Masini L, et al (2012b). Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiotherapy Oncol, 103, 199-205.
  27. Thames HD, Withers HR, Peters LJ, et al (1982). Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Intern J Radiat Oncol Biol Phys, 8, 219-26.
  28. Turesson I, Nyman J, Holmberg E, et al (1996). Prognostic factors for acute and late skin reactions in radiotherapy patients. Intern J Radiat Oncol Biol Phys, 36, 1065-75.
  29. Uziel T, Savitsky K, Platzer M, et al (1996). Genomic Organization of the ATM gene. Genomics, 33, 317-20.
  30. Wang C, Xiao S, Zhang S (2007). Relation between radiotherapy-induced acute injury of mucosa of nasopharyngeal carcinoma and p53 polymorphisms. Suzhou Univers J Med Sci, 27, 875-77.
  31. Xiong H, Liao Z, Liu Z, et al (2013). ATM Polymorphisms Predict Severe Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy. Intern J Radiat Oncol Biol Phys, 85, 1066-73.
  32. Yang M, Zhang L, Bi N, et al (2011). Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys, 79, 1402-7.
  33. Zschenker O, Raabe A, Boeckelmann IK, et al (2010). Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol, 97, 26-32.

Cited by

  1. Genetic susceptibility to cutaneous radiation injury vol.309, pp.1, 2017,